SST (SST) Stock Price & Analysis
SST (SST) rose 30.55% to USD 5 as of September 8, 2026 at 21:33 UTC, according to Nexqual real-time market data.
SST last closed at USD 5; the session ranged USD 3.81–5.45 on volume of 6,109,499 shares. Market capitalization is —, with a 52-week range of USD 1.35–9.3 (NYQ). Source: Nexqual, September 8, 2026 at 21:33 UTC.
Key Statistics (as of September 8, 2026 at 21:33 UTC)
| Price | USD 5 |
|---|---|
| Change | ▲ 30.55% (up) |
| Previous Close | USD 5 |
| Open | USD 5 |
| Day Range | USD 3.81 – 5.45 |
| 52-Week Range | USD 1.35 – 9.3 |
| Volume | 6,109,499 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (SST)
Nexqual's technical model rates SST "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of September 8, 2026 at 21:33 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 88.79 (overbought) |
| vs SMA50 | Above (USD 2.21) |
| MACD | 0.49 (positive) |
From SST's Latest SEC 10-K Filing (filed 2026-03-11)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ANGH | Anghami Inc. | USD 3.46 | ▼ 6.49% |
| BFRI | Biofrontera Inc. | USD 1.56 | ▲ 3.31% |
| HOUR | Hour Loop, Inc. | USD 1.89 | ▲ 0.53% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.47 | ▲ 7.5% |
| SBFM | Sunshine Biopharma Inc. | USD 1.15 | ▲ 3.6% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 21:33 UTC. This page is informational and not investment advice.